Plus Therapeutics Inc (PSTV)
NASDAQ · Healthcare
Plus Therapeutics Inc EPS 2009–2025
Plus Therapeutics Inc annual/quarterly eps history and growth rate from 2009 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Plus Therapeutics Inc eps for the quarter ending March 31, 2026 was $1.05, a 96.48% decrease year-over-year.
- Plus Therapeutics Inc annual eps for 2025 was $0.29, a 87.61% decrease from 2024.
- Plus Therapeutics Inc annual eps for 2024 was $2.34, a 44.81% decrease from 2023.
- Plus Therapeutics Inc annual eps for 2023 was $4.24, a 595.08% increase from 2011.
- Plus Therapeutics Inc annual eps for 2011 was $0.61.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Plus Therapeutics Inc EPS — FAQ
Plus Therapeutics Inc (PSTV) eps over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Plus Therapeutics Inc's eps?
Plus Therapeutics Inc (PSTV) reported eps of $-0.29 for fiscal 2025.
Where can I see PSTV's eps history?
The chart and table above show Plus Therapeutics Inc's eps by year and by quarter, including the growth rate.